Menarini At-a-Glance About the MENARINI Group

The Menarini Group is a privately-held pharmaceutical and

Headquarters: , biotechnology company with a proud 125 year history of delivering therapeutic, diagnostic, and medical device products to Founded: 1886 global healthcare markets.

2012 Turnover: €3.2 billion While Menarini has its roots in Italy, where it has ranked first for Global Workforce: 16,640 many years among those companies operating in the pharmaceutical sector, the Group has built a strong international Operating in more than 100 business and proudly claims 75% of it’s revenues coming from countries outside its home market.

The research programs for the Group are divided up among its centres in Florence, Pomezia, Pisa, Barcelona and Berlin, addressing the medical needs in cardiovascular diseases, oncology and the // areas, primarily with a focus on the study of receptor antagonists.

Menarini Biotech offers a secure, compliant and cost effective partner in the development and manufacture of biologic Milestones medicines derived from mammalian or microbial hosts.

1964 Laboratorios Menarini opens in A. Menarini Diagnostics has more than three decades dedicated to Barcelona (Spain) marking the exceeding the technological needs of Europe’s most prominent company’s first business outside Italy healthcare professionals in the fields of (both Home Glucose Testing and laboratory testing), autoimmunity, urinalysis and cell pathology. 1978 Menarini R&D division formed in conjunction with the introduction of pharmaceutical patents Group Turnover

1992 Berlin-Chemie acquired opening the Central-East European markets to Menarini

2003 Menarini Biotech created to provide product research, development and production capacities

2011 Menarini acquires the Invida Group consolidating and expanding presence in Asia-Pacific

Via Dei Setti Santi 1/3 • Florence Italy 50131 • +39 (0)55 56801 www.menarini.com